About the Authors

Erika J. Lampert

Affiliation Department of Psychiatry, Duke University Medical Center, Durham, North Carolina, United States of America

Kingshuk Roy Choudhury

Affiliation Department of Radiology, Duke University Medical Center, Durham, North Carolina, United States of America

Christopher A. Hostage

Affiliation Department of Radiology, Duke University Medical Center, Durham, North Carolina, United States of America

Jeffrey R. Petrella

Affiliation Department of Radiology, Duke University Medical Center, Durham, North Carolina, United States of America

P. Murali Doraiswamy

murali.doraiswamy@duke.edu

Affiliations Department of Psychiatry, Duke University Medical Center, Durham, North Carolina, United States of America, The Duke Institute for Brain Sciences, Duke University Medical Center, Durham, North Carolina, United States of America

Competing Interests

The Alzheimer’s Disease Neuroimaging Initiative is funded by Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. PMD owns stock in Sonexa and Clarimedix, whose products are not discussed here. Jeffrey Petrella is on the neuroradiology advisory board of Janssen Alzheimer Immunotherapy. There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: PMD KRC JRP. Performed the experiments: JRP PMD. Analyzed the data: EJL KRC PMD. Contributed reagents/materials/analysis tools: JRP CAH KRC PMD. Wrote the paper: EJL PMD CAH KRC.